Scancell Holdings doses first patient with iSCIB1+ : compare

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its...

Related Keywords

Ls Prasad Kellati , Lindy Durrant , Scancell Avidimab , Scancell Holdings , Royal Preston ,